Alnylam Pharmaceuticals
ALNY
#1073
Rank
โ‚ฌ20.04 B
Marketcap
149,66ย โ‚ฌ
Share price
5.36%
Change (1 day)
-61.78%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company